Thomas Shenk
28Patents
10h-index
22Co-inventors
75Inventor score
Filing activity: Dec 11, 1986 → Aug 12, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5436146A | Helper-free stocks of recombinant adeno-associated virus vectors | Chemistry; Metallurgy | 233 | Expired |
| US5753500A | Helper-free stocks of recombinant adeno-associated virus vectors | Chemistry; Metallurgy | 110 | Expired |
| US5382510A | Methods of diagnosing pre-cancer or cancer states using probes for detecting mutant p53 | Physics | 79 | Expired |
| US4882269A | Amplified hybridization assay | Emerging Cross-Sectional Technologies | 74 | Expired |
| US6951753B2 | Helper-free stocks of recombinant adeno-associated virus vectors | Chemistry; Metallurgy | 65 | Expired |
| US5424188A | Amplified hybridization assay | Emerging Cross-Sectional Technologies | 37 | Expired |
| US8173362B2 | Cytomegalovirus surface protein complex for use in vaccines and as a drug target | Physics | 25 | Active |
| US6936416B2 | Expression monitoring for human cytomegalovirus (HCMV) infection | Physics | 12 | Expired |
| US7704510B2 | Cytomegalovirus surface protein complex for use in vaccines and as a drug target | Physics | 11 | Active |
| US6489162B1 | Helper-free stocks of recombinant adeno-associated virus vectors | Chemistry; Metallurgy | 10 | Expired |
| US5674730A | Eukaryotic cells comprising a DNA sequence encoding a bacterial-viral chimeric transactivator protein | Chemistry; Metallurgy | 10 | Expired |
| US8158677B2 | Treatment of viral infections by modulation of host cell metabolic pathways | Emerging Cross-Sectional Technologies | 5 | Active |
| US9168269B2 | Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals | Human Necessities | 5 | Active |
| US5620848A | Methods for detecting mutant p53 | Physics | 4 | Expired |
| US8828399B2 | Cytomegalovirus surface protein complex for use in vaccines and as a drug target | Physics | 3 | Active |
| US9029413B2 | Treatment of viral infections by modulation of host cell metabolic pathways | Emerging Cross-Sectional Technologies | 2 | Active |
| US5770720A | Ubiquitin conjugating enzymes having transcriptional repressor activity | Chemistry; Metallurgy | 2 | Expired |
| US10174290B2 | Method to increase the infectivity of virus particles | Chemistry; Metallurgy | 1 | Active |
| US9439960B2 | Cytomegalovirus vaccines and methods of production | Chemistry; Metallurgy | 1 | Active |
| US11129891B2 | Cytomegalovirus surface protein complex for use in vaccines and as a drug target | Physics | 0 | Active |
| US9149445B2 | Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections | Human Necessities | 0 | Active |
| US11726088B2 | Sirtuin 4 (SIRT4) lipoamidase activity and uses thereof | Physics | 0 | Active |
| US11008551B2 | Method to increase the infectivity of virus particles | Chemistry; Metallurgy | 0 | Active |
| US9212349B2 | Method to produce virus in cultured cells | Chemistry; Metallurgy | 0 | Active |
| US10300130B2 | Cytomegalovirus vaccines and methods of production | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.